InvestorsHub Logo
Followers 239
Posts 12042
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Friday, 11/01/2019 4:00:55 PM

Friday, November 01, 2019 4:00:55 PM

Post# of 689034
November seems to be off to a great start with many biotech's I'm invested in, or follow. NWBO while far from my biggest gain today could prove to be a tremendous gainer this month, possibly even without the trial being unblinded, if substantial additional information comes out of presentations later this month.

Certainly I'm hoping we'll unblind, but that will mean the SAP's been submitted, I don't know that we'll be told of that happening. I would think we'll see top line data a matter of days after the SAP submission as after that event, things can happen in a big hurry. If in fact it's unblinded, but everything can't be presented at SNO, it could still be a major presentation, and the remainder of the details could be presented at ASCO. If I remember correctly, while ASCO's not until late May or early June, it's Abstracts are due in February. If the trial is presented in complete detail at SNO, we'd need to have something more to add if we're to get a presentation at ASCO.

Gary

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News